Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04485949 |
|---|---|
| Brief Title: | A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma |
| First Submitted : | July 22, 2020 |
| First Submitted that Met QC Criteria : | July 22, 2020 |
| First Posted : | July 24, 2020 |
| Last Update Submitted that Met QC Criteria : | March 1, 2024 |
| Last Update Posted : | March 5, 2024 |